Advances in biomaterials for the treatment of retinoblastoma
Retinoblastoma is the most common primary intraocular malignancy in children. Although
traditional chemotherapy has shown some success in retinoblastoma management, there …
traditional chemotherapy has shown some success in retinoblastoma management, there …
Advances in biomaterials for the treatment of retinoblastoma
W Farhat, V Yeung, A Ross, F Kahale… - Biomaterials …, 2022 - pubmed.ncbi.nlm.nih.gov
Retinoblastoma is the most common primary intraocular malignancy in children. Although
traditional chemotherapy has shown some success in retinoblastoma management, there …
traditional chemotherapy has shown some success in retinoblastoma management, there …
Advances in biomaterials for the treatment of retinoblastoma.
W Farhat, V Yeung, A Ross, F Kahale… - Biomaterials …, 2022 - europepmc.org
Retinoblastoma is the most common primary intraocular malignancy in children. Although
traditional chemotherapy has shown some success in retinoblastoma management, there …
traditional chemotherapy has shown some success in retinoblastoma management, there …